Livzon Pharma Publishes 2026 Q3 Report, Profit Distribution Proposal and 2026–2028 Shareholder Return Plan

Bulletin Express
10/23

Livzon Pharmaceutical Group Inc. (Livzon Pharma) released several key corporate documents on 23 October 2026. The English and Chinese versions of the following materials are now available on both the company’s website (www.livzon.com.cn) and the HKEX platform (www.hkexnews.hk):

• 2026 Third Quarterly Report • Circular dated 23 October 2026 • Notice and Proxy Form for the 2026 Second Extraordinary General Meeting • Profit Distribution Proposal for the first three quarters of 2026 • Shareholder Return Plan covering 2026–2028

Registered shareholders who have elected to receive printed communications will receive hard-copy versions with the current mailing. Shareholders preferring printed materials—or those unable to access electronic versions—can request hard copies free of charge by completing the enclosed request form and returning it to the Hong Kong branch share registrar, Tricor Investor Services Limited, at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, or by emailing 1513-ecom@vistra.com.

To ensure prompt electronic delivery of future corporate communications and actionable documents, shareholders are advised to provide or update a functional email address via the same request form. Until a valid email address is on record, all notices of publication and actionable documents will be sent in printed form.

Enquiries can be directed to Tricor Investor Services Limited’s hotline at (852) 2980 1333, Monday to Friday, 9:00 a.m.–6:00 p.m. (excluding public holidays). Livzon Pharma’s board secretary, Liu Ning, signed the notice on behalf of the board.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10